Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Sarana Medika Tbk. (DKHH) vs Zyrexindo Mandiri Buana Tbk. (ZYRX) Price & Performance

Cipta Sarana Medika Tbk.Trade
Zyrexindo Mandiri Buana Tbk.Trade

Price performance (Past 24H)

Key statistics

Cipta Sarana Medika Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 163.22B, 3.92M 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp129 (market cap 178.67B, 949.3K 24h volume). The key difference: Cipta Sarana Medika Tbk. and Zyrexindo Mandiri Buana Tbk. are close in size by market cap, and Cipta Sarana Medika Tbk. is more actively traded (3.92M versus 949.3K). Which is the better fit depends on your goals.

DKHHZYRX
Market Cap
163.22B178.67B
Volume
3.92M949.3K
Lot
39.16K9.49K
Turnover
249.6M122.87M
Average Price
63.74129.43
Value
249.6M122.87M
Indicative Equilibrium Price
64129
Indicative Equilibrium Volume
7748

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKHH
View details
ZYRX
View details

About Cipta Sarana Medika Tbk.

PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.

Read more on DKHH

About Zyrexindo Mandiri Buana Tbk.

PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik

Read more on ZYRX